Welcome to our dedicated page for Axos Financial SEC filings (Ticker: AX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Axos Financial, Inc. filings document the bank holding company’s operating results, material events, capital structure and public-company disclosures. Its SEC records identify common stock with a $0.01 par value listed on the New York Stock Exchange under AX and include 8-K reports for quarterly results, earnings supplements and Regulation FD investor presentations.
The filings also cover disclosure areas tied to Axos Bank, Axos Clearing LLC and Axos Invest, Inc., including Banking Business and Securities Business segment results, material agreements, shareholder voting matters, bank regulatory matters, risk language and capital-structure information.
Thomas Constantine submitted a Form 144 notice related to proposed/rescheduled disposition of common stock tied to AX. The filing lists a past three‑month sale of 1,594 shares on 06/08/2026 for $140,574.86 and references 400 restricted shares dated 03/20/2026.
The filing names Morgan Stanley Smith Barney LLC as the broker and indicates the securities trade on the NYSE. This is a routine insider filing reporting small-dollar transactions and a proposed/reserved sale of restricted shares.
Axos Financial, Inc. reported that on June 8, 2026, the Office of the Comptroller of the Currency approved a planned deposit acquisition by its subsidiary, Axos Bank. This regulatory approval is a key step that allows the bank to move forward with the previously disclosed transaction.
The company currently expects the deposit acquisition to close later in calendar year 2026, pending completion of any remaining closing conditions and processes. No financial terms of the transaction are described in this disclosure.
AX filing a Form 144 notice through Morgan Stanley Smith Barney LLC Executive Financial Services. The notice lists proposed sales of Common Stock described as Restricted Stock with transaction dates 03/15/2026 and a filing/date entry of 06/08/2026. The excerpt shows two lots of restricted shares: 864 and 730 shares, each labeled "Issuer" and dated 03/15/2026. The filing identifies the broker and the exchange as NYSE.
Axos Financial, Inc. executive Michael James Watson reported an open-market sale of common stock. He sold 1,653 shares of Axos common stock on May 19, 2026 at a weighted average price of $83.769 per share, executed in multiple trades between $83.75 and $83.79. After this transaction, he directly owned 4,592 shares and indirectly held 777 shares through a 401(k) Plan.
Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 notice relating to Common stock tied to restricted stock transactions. The filing lists 1,653 shares in the securities row and individually shows 487 shares dated 09/15/2025, 726 shares dated 09/15/2025, and 440 shares dated 09/23/2025.
Axos Financial, Inc. director James S. Argalas made a bona fide charitable gift of 2,100 shares of common stock. The shares were valued at $84.66 each, for a total donation of $177,786. Following the donation, he holds 71,240 common shares directly.
Axos Financial, Inc. director Santi A. Roque reported an open-market sale of the company’s common stock. He sold 500 shares of Axos common stock at an average price of $87.77 per share on May 8, 2026. After this transaction, he continues to hold 7,646 shares directly, indicating that the sale represents only a portion of his total reported holdings.
Axos Financial, Inc. shares an investor presentation outlining strong recent performance and its diversified digital banking model. For the fiscal third quarter 2026, assets grew 22%, deposits grew 11%, net income rose 19%, and diluted EPS increased 19% to $2.15.
The company reports consolidated return on equity of 16.26% and return on assets of 1.77%, with Axos Bank ranking in the 93rd percentile of peers for both ROE and ROAA and a top-tier net interest income percentile. Approximately 85% of deposits are FDIC-insured or collateralized, with total deposits of $22.4 billion as of March 31, 2026.
Axos highlights diversified lending across consumer, commercial, and securities businesses, resilient net interest margin of 4.76%, and growing non-interest income, which is annualized at $344.0 million for the quarter ended March 31, 2026 versus $103.0 million in fiscal 2020. Management also emphasizes holistic credit risk management, relatively low loan-to-value commercial real estate specialty exposures, and technology-driven efficiency and scalability across its universal digital bank platform.
Axos Financial, Inc. announced that its subsidiary, Axos Bank, completed the acquisition of all United States consumer deposits of Jenius Bank, the digital banking business of SMBC MANUBANK, on May 2, 2026. The Bank acquired approximately $2.3 billion of deposits from Jenius Bank and received cash, less a negotiated premium, under a Purchase and Assumption Agreement dated February 12, 2026. The full agreement is incorporated by reference as an exhibit.
Axos Financial, Inc. reported solid growth for the quarter ended March 31, 2026. Net income rose to $124.7 million from $105.2 million a year earlier, with diluted earnings per share increasing to $2.15 from $1.81. For the nine-month period, net income reached $365.4 million versus $322.2 million, and diluted EPS climbed to $6.33 from $5.55, reflecting higher net interest income and sharply higher non-interest income.
Total assets expanded to $29.25 billion from $24.78 billion at June 30, 2025, driven by loan growth to $25.47 billion of gross loans and deposits rising to $22.39 billion. Axos closed the all-cash acquisition of Verdant Commercial Capital, adding about $1.2 billion of loans and leases, and purchased a $125 million San Diego office campus for its future headquarters. It also signed agreements to acquire approximately $2.3 billion of Jenius Bank deposits and about $3.2 billion of IRA deposits from Capital One, pending or following regulatory approvals.